SCHEMBL3973363

SCHEMBL3973363

COS(=O)(=O)[O-].C[N+](C)(C)CCOc1ccc(N)cn1

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
BRCA1 P38398 1/20 0.36
HBB P68871 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3969613 0.81 KMT2A (0.43) POLBMEN1KMT2ACYP2C19RAB9A
SCHEMBL3965944 0.75 CYP1A2 (0.47) LMNAPOLBCHRNB2CHRNA4MEN1
SCHEMBL15016415 0.74 MAPT (0.40) LMNAKDM4EMEN1ALDH1A1KMT2A
SCHEMBL2228846 0.72 CA12 (0.41) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL23634035 0.72 KDM4E (0.50) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL29837272 0.72 KDM4E (0.50) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL2228978 0.71 PIK3CA (0.49) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL29837257 0.70 KDM4E (0.48) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL29837259 0.70 KDM4E (0.48) POLBKDM4EMEN1ALDH1A1BRCA1
SCHEMBL16322624 0.69 KDM4E (0.50) POLBKDM4EMEN1ALDH1A1BRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517367-B2 Cationic naphthyldiazo dyes and keratin fibers-coloring agents containing these dyes WELLA AG (DE) 2009-04-14 US disclosed
US-20080167453-A1 Cationic Naphthyldiazo Dyes and Keratin Fibers-Coloring Agents Containing These Dyes WELLA AG (DE) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167453-A1 Cationic Naphthyldiazo Dyes and Keratin Fibers-Coloring Agents Containing These Dyes KRT18, KPNB1, KPNA3 LMNA 25/4885POLB 1055/4885CHRNB2 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.